BioXcel Therapeutics (BTAI) Institutional Ownership $1.39 -0.03 (-2.11%) Closing price 04:00 PM EasternExtended Trading$1.40 +0.01 (+0.36%) As of 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BioXcel Therapeutics (NASDAQ:BTAI)CurrentInstitutional OwnershipPercentage30.68%Number ofInstitutional Buyers(last 12 months)10TotalInstitutional Inflows(last 12 months)$56.92MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$3.89M Get BTAI Insider Trade Alerts Want to know when executives and insiders are buying or selling BioXcel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BTAI Institutional Buying and Selling by Quarter BioXcel Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025 Goldman Sachs Group Inc.24,794$50K0.0%N/A0.452% 5/16/2025 Murchinson Ltd.136,076$276K0.0%N/A2.480% 2/17/2025 Squarepoint Ops LLC72,046$27K0.0%+203.9%0.145% 2/17/2025 Millennium Management LLC104,972$39K0.0%-18.5%0.212% 2/14/2025 Northern Trust Corp73,910$28K0.0%+81.4%0.149% 2/13/2025 Renaissance Technologies LLC77,900$29K0.0%-40.0%0.157% 2/13/2025 Wells Fargo & Company MN199,010$74K0.0%+7.5%0.401% 2/12/2025 Geode Capital Management LLC311,965$117K0.0%+4.7%0.629% 11/15/2024 Jane Street Group LLC49,317$30K0.0%-60.6%0.121% 11/15/2024 State Street Corp77,149$47K0.0%-38.2%0.189% Get the Latest News and Ratings for BTAI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioXcel Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/13/2024 BNP Paribas Financial Markets44,381$27K0.0%-83.8%0.109% 9/16/2024 Point72 Asia Singapore Pte. Ltd.30,295$39K0.0%N/A0.081% 8/15/2024 Armistice Capital LLC2,987,000$3.82M0.0%+705.2%7.959% 8/15/2024 Point72 Asia Singapore Pte. Ltd.30,295$39K0.0%N/A0.081% 8/12/2024 XTX Topco Ltd46,503$60K0.0%+49.0%0.124% 7/12/2024 Rosalind Advisors Inc.39,672$51K0.0%N/A0.106% 5/20/2024 Virtu Financial LLC13,990$39K0.0%-76.5%0.037% 5/10/2024 Vanguard Group Inc.1,099,375$3.10M0.0%+0.9%2.968% 2/26/2024 Virtu Financial LLC59,514$176K0.0%N/A0.196% 2/14/2024 Pennant Investors LP83,900$248K0.1%N/A0.276% 2/13/2024 Tower Research Capital LLC TRC13,832$41K0.0%+239.2%0.046% 2/6/2024 Apollon Wealth Management LLC10,537$31K0.0%N/A0.035% 2/2/2024 Truist Financial Corp10,879$32K0.0%N/A0.036% 1/23/2024 DAVENPORT & Co LLC35,385$104K0.0%-42.5%0.118% 12/6/2023 Citigroup Inc.24,336$62K0.0%-59.5%0.083% 11/15/2023 Adage Capital Partners GP L.L.C.200,000$506K0.0%-89.8%0.683% 11/13/2023 FMR LLC2,700,727$6.83M0.0%-38.2%9.227% 10/27/2023 Hennion & Walsh Asset Management Inc.33,940$86K0.0%+89.5%0.116% 10/24/2023 Bank of New York Mellon Corp128,022$324K0.0%+13.2%0.437% 10/12/2023 SeaCrest Wealth Management LLC16,550$42K0.0%-20.0%0.057% 8/14/2023 Driehaus Capital Management LLC22,220$148K0.0%-94.3%0.076% 8/11/2023 E Fund Management Co. Ltd.10,628$71K0.0%N/A0.036% 8/10/2023 Profund Advisors LLC35,475$236K0.0%+29.2%0.122% 8/10/2023 US Bancorp DE14,072$94K0.0%+42,542.4%0.048% 8/9/2023 BNP Paribas Arbitrage SNC69,994$466K0.0%-38.5%0.240% 7/25/2023Raymond James & Associates18,648$124K0.0%+32.7%0.064% 7/20/2023 DAVENPORT & Co LLC59,705$398K0.0%-25.6%0.205% 7/19/2023 Artemis Investment Management LLP895,048$5.96M0.1%-8.8%3.069% 7/14/2023 SeaCrest Wealth Management LLC20,700$138K0.0%+38.9%0.071% 5/12/2023AlphaCentric Advisors LLC40,000$746K0.5%-20.0%0.138% Trump wipes out trillions overnight… (Ad)Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.Whether you take some of that wealth for yourself depends on if you watch this controversial exposé 5/12/2023 SeaCrest Wealth Management LLC14,907$278K0.0%N/A0.051% 5/12/2023 Profund Advisors LLC27,462$512K0.0%N/A0.095% 5/11/2023 FMR LLC4,276,693$79.80M0.0%+1.7%14.742% 5/11/2023 Citigroup Inc.118,975$2.22M0.0%+19,120.5%0.410% 5/10/2023 Tocqueville Asset Management L.P.37,000$690K0.0%-6.1%0.128% 5/8/2023 Federated Hermes Inc.61,730$1.15M0.0%N/A0.213% 5/8/2023 Zurcher Kantonalbank Zurich Cantonalbank12,103$226K0.0%+8.2%0.042% 5/5/2023 Truist Financial Corp11,353$212K0.0%-4.9%0.039% 5/5/2023 Artemis Investment Management LLP981,472$18.28M0.2%-26.4%3.383% 5/4/2023 Barclays PLC56,023$1.05M0.0%+990.8%0.193% 5/4/2023 Mirae Asset Global Investments Co. Ltd.14,137$264K0.0%N/A0.049% 4/27/2023 DAVENPORT & Co LLC80,295$1.50M0.0%-48.9%0.277% 4/21/2023 Capital Investment Advisory Services LLC17,325$323K0.0%N/A0.060% 4/20/2023 Hennion & Walsh Asset Management Inc.37,887$707K0.0%-3.3%0.131% 4/14/2023Raymond James & Associates14,052$262K0.0%-11.8%0.048% 4/13/2023 Allspring Global Investments Holdings LLC49,311$920K0.0%N/A0.170% 2/14/2023 Driehaus Capital Management LLC505,934$10.87M0.2%N/A1.806% 2/10/2023 Sectoral Asset Management Inc.61,156$1.31M0.3%N/A0.218% 2/9/2023 Tocqueville Asset Management L.P.39,400$846K0.0%+37.5%0.141% 2/8/2023 UBS Group AG139,214$2.99M0.0%-2.9%0.497% 2/1/2023 Zurcher Kantonalbank Zurich Cantonalbank11,182$240K0.0%+50.0%0.040% 1/25/2023 Artemis Investment Management LLP1,333,691$28.75M0.3%-3.0%4.760% 1/20/2023 DAVENPORT & Co LLC157,105$3.38M0.0%+44.7%0.561% 1/12/2023 Hennion & Walsh Asset Management Inc.39,185$842K0.1%+14.5%0.140% 11/10/2022 Connor Clark & Lunn Investment Management Ltd.17,452$206K0.0%N/A0.062% 11/10/2022 UBS Group AG143,388$1.70M0.0%+22.5%0.512% 11/9/2022 Massachusetts Financial Services Co. MA453,877$5.37M0.0%+7.3%1.620% 11/8/2022AlphaCentric Advisors LLC50,000$591K0.6%N/A0.178% 11/7/2022 Quantbot Technologies LP4,879$57K0.0%N/A0.017% 11/7/2022 Jump Financial LLC26,000$307K0.0%+22.2%0.093% 10/26/2022 Truist Financial Corp23,307$275K0.0%+16.7%0.083% 10/25/2022 Artemis Investment Management LLP1,374,496$16.26M0.2%-0.8%4.905% 10/13/2022PVG Asset Management Corp15,040$178K0.7%N/A0.054% 10/11/2022 DAVENPORT & Co LLC108,545$1.28M0.0%+26.7%0.387% 8/13/2022 Massachusetts Financial Services Co. MA423,021$5.58M0.0%-0.7%1.511% 8/12/2022 Virtus ETF Advisers LLC11,284$149K0.1%+46.3%0.040% 8/11/2022 Alps Advisors Inc.16,596$219K0.0%-42.3%0.059% 8/8/2022 Walleye Capital LLC36,896$487K0.0%N/A0.132% 8/5/2022 State Board of Administration of Florida Retirement System17,112$226K0.0%+45.0%0.061% 8/4/2022 Game Plan Financial Advisors LLC10,880$142K0.1%N/A0.039% 7/29/2022 SG Americas Securities LLC43,468$574K0.0%N/A0.155% 7/29/2022 Crossmark Global Holdings Inc.12,083$159K0.0%N/A0.043% 7/22/2022 Truist Financial Corp19,974$264K0.0%+3.6%0.071% 7/22/2022 Artemis Investment Management LLP1,384,938$18.31M0.2%-3.0%4.948% 7/18/2022 DAVENPORT & Co LLC85,670$1.13M0.0%+154.3%0.306% 6/30/2022 Amalgamated Bank2,816$59K0.0%N/A0.010% 5/17/2022 HITE Hedge Asset Management LLC12,768$267K0.0%-22.1%0.046% 5/13/2022 Apis Capital Advisors LLC40,000$836K1.0%N/A0.143% 5/11/2022 Massachusetts Financial Services Co. MA426,177$8.91M0.0%+2.8%1.523% 5/2/2022 DAVENPORT & Co LLC33,682$704K0.0%-2.9%0.120% Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos4/29/2022 Nisa Investment Advisors LLC12,600$263K0.0%N/A0.045% 4/26/2022 Hennion & Walsh Asset Management Inc.35,221$736K0.0%+2.1%0.126% 4/22/2022 Truist Financial Corp19,280$403K0.0%N/A0.069% 4/21/2022 Artemis Investment Management LLP1,428,228$29.86M0.2%+1.3%5.104% 2/25/2022AlphaCentric Advisors LLC50,000$1.02M0.3%N/A0.179% 2/14/2022 Virtus ETF Advisers LLC8,164$166K0.1%+47.1%0.029% 2/14/2022 Alliancebernstein L.P.1,508,768$30.67M0.0%+47.9%5.392% 2/11/2022 CNA Financial Corp14,359$292K0.1%+42.5%0.051% 2/11/2022 Ensign Peak Advisors Inc5,400$110K0.0%N/A0.019% 2/10/2022 Rafferty Asset Management LLC98,638$2.01M0.0%+64.9%0.353% (Data available from 1/1/2016 forward) BTAI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BTAI shares? During the previous two years, 35 institutional investors and hedge funds held shares of BioXcel Therapeutics. The most heavily invested institutionals were FMR LLC ($6.83M), Artemis Investment Management LLP ($5.96M), Armistice Capital LLC ($3.82M), Vanguard Group Inc. ($3.10M), Adage Capital Partners GP L.L.C. ($506K), BNP Paribas Arbitrage SNC ($466K), and Bank of New York Mellon Corp ($324K).Learn more on BTAI's institutional investors. What percentage of BioXcel Therapeutics stock is owned by institutional investors? 30.68% of BioXcel Therapeutics stock is owned by institutional investors. Learn more on BTAI's institutional investor holdings. Which institutional investors have been buying BioXcel Therapeutics stock? Of the 23 institutional investors that purchased BioXcel Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($2.62M), Murchinson Ltd. ($136.08K), Pennant Investors LP ($83.90K), Point72 Asia Singapore Pte. Ltd. ($60.59K), Virtu Financial LLC ($59.51K), Squarepoint Ops LLC ($48.34K), and Rosalind Advisors Inc. ($39.67K). How much institutional buying is happening at BioXcel Therapeutics? Institutional investors have bought a total of 3,260,319 shares in the last 24 months. This purchase volume represents approximately $71.45M in transactions. Which BioXcel Therapeutics major shareholders have been selling company stock? Of the 14 institutional investors that sold BioXcel Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adage Capital Partners GP L.L.C. ($1.75M), FMR LLC ($1.67M), Driehaus Capital Management LLC ($366.55K), BNP Paribas Financial Markets ($228.75K), Artemis Investment Management LLP ($86.42K), Jane Street Group LLC ($75.73K), and Renaissance Technologies LLC ($51.97K). How much institutional selling is happening at BioXcel Therapeutics? Institutional investors have sold a total of 4,481,928 shares in the last 24 months. This volume of shares sold represents approximately $202.57M in transactions. Related Companies bluebird bio Major Shareholders Kezar Life Sciences Major Shareholders FibroGen Major Shareholders Marinus Pharmaceuticals Major Shareholders MiNK Therapeutics Major Shareholders Allakos Major Shareholders Scilex Major Shareholders CalciMedica Major Shareholders Grace Therapeutics Major Shareholders Surrozen Major Shareholders This page (NASDAQ:BTAI) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioXcel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioXcel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BTAI Stock Free BTAI Stock Alerts